ABIONYX Pharma

About ABIONYX Pharma

ABIONYX Pharma is a new-generation biotech company focused on contributing to health through innovative therapies for indications where no effective or existing treatments are available, including rare conditions. The company collaborates with partners in research, medicine, bioproduct supply, and shareholders to develop drugs for renal and ophthalmological diseases, as well as new HDL vectors for targeted drug delivery.

Products & Services

CER 001:A therapeutic asset under development, likely focused on specific medical indications.

Specialties

Innovative therapies for rare conditions Renal disease treatments Ophthalmological disease treatments HDL vectors for targeted drug delivery

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 9443700 MR: - FA: €8.7 million FAN: 9443700	D: 2025-02-20 FD: 2025-02-20	1 investors

Grant Latest

2025-02-20

$9.4M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

ABIONYX Pharma Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised